See the DrugPatentWatch profile for fosamax
The cost of Fosamax (alendronate) with Medicare can vary depending on several factors, including your specific Medicare plan, the pharmacy you use, and whether you are using a generic or brand-name version of the medication.
How Does Medicare Cover Fosamax?
Medicare Part D plans, which cover prescription drugs, generally cover Fosamax. However, the exact coverage, copayments, and deductibles will depend on the formulary (list of covered drugs) of your chosen Part D plan [1]. Some plans may place Fosamax on a preferred tier, which could result in lower out-of-pocket costs [2].
Generic vs. Brand-Name Fosamax Costs
The generic version of Fosamax is alendronate. Generic medications are typically less expensive than their brand-name counterparts. If your Medicare plan covers both, opting for generic alendronate will likely result in lower costs [2].
What Might Your Copay Be?
Without a specific Medicare plan in hand, it is difficult to state an exact copay. Copayments can range from a few dollars to significantly more, depending on your plan's structure and whether you have met your deductible [1]. For example, a plan might have a $10 copay for generic drugs in a preferred tier, or it could be a percentage of the drug's cost [2].
Can You Get Lower Prices for Fosamax?
Patients may find ways to reduce their out-of-pocket expenses for Fosamax. These can include:
* Comparing prices at different pharmacies [3].
* Checking if your Medicare plan offers a mail-order option, which can sometimes be cheaper [2].
* Exploring patient assistance programs offered by the drug manufacturer or independent organizations, although eligibility requirements apply [3].
* Utilizing discount cards or coupons, which can offer savings on both brand-name and generic prescriptions [3].
When Does Fosamax Patent Exclusivity End?
The original patent exclusivity for brand-name Fosamax has long since expired, allowing for the availability of generic alendronate [4]. This is a common occurrence for many medications, leading to increased competition and generally lower prices.
---
Sources:
[1] Medicare.gov
[2] DrugPatentWatch.com
[3] NeedyMeds
[4] U.S. Food and Drug Administration (FDA)